SCHEMBL7411527

SCHEMBL7411527

CC(C)(C)OC(=O)N1CCCCC1CC=Cc1cccs1

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 1/20 0.43
PDE8B O95263 1/20 0.41
ALDH1A1 P00352 3/20 0.40
SMN1; SMN2 Q16637 3/20 0.40
KCNH2 Q12809 1/20 0.40
MEN1 O00255 1/20 0.39
LMNA P02545 1/20 0.39
TSHR P16473 1/20 0.39
KMT2A Q03164 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
OPRD1 P41143 1/20 0.39
ATM Q13315 2/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
MAPT P10636 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
GPR119 Q8TDV5 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7819385 1.00 KDM1A (0.43) KDM1APDE8BALDH1A1SMN1; SMN2KCNH2
SCHEMBL6728212 0.84 PARP1 (0.40) ALDH1A1SMN1; SMN2LMNANPC1RAB9A
SCHEMBL6728211 0.84 PARP1 (0.40) ALDH1A1SMN1; SMN2LMNANPC1RAB9A
SCHEMBL7816624 0.84 MEN1 (0.54) KDM1APDE8BALDH1A1MEN1LMNA
SCHEMBL7417065 0.84 MEN1 (0.54) KDM1APDE8BALDH1A1MEN1LMNA
SCHEMBL7415809 0.81 ALDH1A1 (0.43) ALDH1A1SMN1; SMN2KCNH2NPC1RAB9A
SCHEMBL7415804 0.81 ALDH1A1 (0.43) ALDH1A1SMN1; SMN2KCNH2NPC1RAB9A
SCHEMBL7415471 0.81 KMT2A (0.44) KDM1APDE8BALDH1A1KCNH2MEN1
SCHEMBL7415474 0.81 KMT2A (0.44) KDM1APDE8BALDH1A1KCNH2MEN1
SCHEMBL7414409 0.80 MEN1 (0.57) KDM1AALDH1A1MEN1LMNATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0734379-B1 2-ARYLALKENYL-AZACYCLOALKANE DERIVATIVES AS SIGMA RECEPTOR LIGANDS, PREPARATION METHOD THEREFOR AND THERAPEUTICAL USE THEREOF PARKE DAVIS (FR) 2001-03-07 EP disclosed
EP-0995436-A2 Ligands for sigma receptors and their therapeutical applications PARKE-DAVIS (FR) 2000-04-26 EP disclosed
US-6013656-A PSYCHOLOGICAL DISORDERS; GASTROINTESTINAL DISORDERS; NERVOUSSYSTEM DISORDERS WARNER-LAMBERT COMPANY (US) 2000-01-11 US disclosed
US-5849760-A 2-(arylalkenyl)azacycloalkane derivatives as ligands for sigma receptors INSTITUT DE RECHERCHE JOUVEINAL (FR) 1998-12-15 US disclosed
WO-1995015948-A1 NOVEL 2-ARYLALKENYL-AZACYCLOALKANE DERIVATIVES AS SIGMA RECEPTOR LIGANDS, PREPARATION METHOD THEREFOR AND THERAPEUTICAL USE THEREOF INSTITUT DE RECHERCHE JOUVEINAL (FR) 1995-06-15 WO disclosed